Differential effects of allergens and irritants on early differentiating monocyte-derived dendritic cells

European Journal of Dermatology

Volumn 18, Issue 2, 2008, Pages 141-147

  Furio, Laetitia ^a   Guezennec, Anne ^b   Ducarre, Blandine ^a   Guesnet, Joelle ^b   Peguet Navarro, Josette ^a  

^a UNIVERSITÉ LYON 1   (France)

^b YSL Beauté ^*  (France)

Author keywords

Allergens; Alternative methods; Contact hypersensitivity; Dendritic cells; Phenotypic modifications

Indexed keywords

ALLERGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CINNAMALDEHYDE; INTERCELLULAR ADHESION MOLECULE 1; IRRITANT AGENT; NICKEL SULFATE; T6 ANTIGEN; THIAZOLIDINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTACT ALLERGY; DENDRITIC CELL; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PHENOTYPE; PHENOTYPIC VARIATION; SCREENING TEST; SKIN CULTURE;

ALLERGENS; ANTIGENS, SURFACE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; DRUG EVALUATION, PRECLINICAL; HUMANS; IRRITANTS; MONOCYTES; PHENOTYPE;

EID: 42349100022     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0351     Document Type: Article

References (29)

1. Diepgen TL, Kanerva L. Occupational skin diseases. Eur J Dermatol 2006; 16: 324-30.
2. Buehler EV. Delayed Contact Hypersensitivity in the Guinea Pig. Arch Dermatol 1965; 91: 171-7.
3. Magnusson B, Kligman AM. The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol 1969; 52: 268-76.
4. Gerberick GF, Ryan CA, Kimber I, Dearman RJ, Lea LJ, Basketter DA. Local lymph node assay: validation assessment for regulatory purposes. Am J Contact Dermat 2000; 11: 3-18.
5. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145: 2833-8.
6. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, Clausen BE. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005; 169: 569-76.
7. Aiba S, Katz SI. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 1990; 145: 2791-6.
8. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-96.
9. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993; 361: 82-5.
10. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, Blankenstein T, Henning G, Forster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004; 21: 279-88.
11. Kobayashi Y, Staquet MJ, Dezutter-Dambuyant C, Schmitt D. Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact. Eur J Immunol 1994; 24: 2254-7.
12. Krasteva M, Peguet-Navarro J, Moulon C, Courtellemont P, Redziniak G, Schmitt D. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells - a screening predictive assay for contact sensitizers. Clin Exp Allergy 1996; 26: 563-70.
13. Rambukkana A, Pistoor FH, Bos JD, Kapsenberg ML, Das PK. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein. Lab Invest 1996; 74: 422-36.
14. Verrier AC, Schmitt D, Staquet MJ. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells. Int Arch Allergy Immunol 1999; 120: 56-62.
15. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-18.
16. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258-61.
17. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998; 187: 961-6.
18. Cluzel-Tailhardat M, Bonnet-Duquennoy M, Abaibou H, Pelle De Queral D, Vocanson M, Lazou K, Kurfurst R, Courtellemont P, Le Varlet B. Which house-keeping genes for dendritic cell transcriptomic studies? Eur J Dermatol 2007; 17: 457-9.
19. Reutter K, Jager D, Degwert J, Hoppe U. In vitro model for contact sensitization: II. Induction of IL-1β mRNA in human blood-derived dendritic cells by contact sensitizers. Toxicol In Vitro 1997; 11: 619-23.
20. Aiba S, Terunuma A, Manome H, Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 1997; 27: 3031-8.
21. Degwert J, Steckel F, Hoppe U, Kligman LH. In vitro model for contact sensitization: I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. Toxicol In Vitro 1997; 11: 613-8.
22. Coutant KD, de Fraissinette AB, Cordier A, Ulrich P. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol Sc 1999; 52: 189-98.
23. Guironnet G, Dalbiez-Gauthier C, Rousset F, Schmitt D, Peguet-Navarro J. In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells. Toxicol In Vitro 2000; 14: 517-22.
24. Tuschl H, Kovac R. Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol In Vitro 2001; 15: 327-31.
25. Staquet MJ, Sportouch M, Jacquet C, Schmitt D, Guesnet J, Péguet-Navarro J. Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells. Toxicol In Vitro 2004; 18: 493-500.
26. Hulette BA, Ryan CA, Gerberick GF. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol Appl Pharmacol 2002; 182: 226-33.
27. Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, Brousse N, Amigorena S, Hermine O, Durandy A. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 1999; 162: 4567-75.
28. Tuschl H, Kovac R, Weber E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol In Vitro 2000; 14: 541-9.
29. Aiba S, Manome H, Yoshino Y, Tagami H. In vitro treatment of human transforming growth factor-beta 1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 2000; 101: 68-75.